You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Candesartan cilexetil

Showing 1 - 25 of 156
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypertension Trial in Brazil (candesartan cilexetil + chlorthalidone + amlodipine, Exforge HCT® (valsartan 160mg +

Not yet recruiting
  • Hypertension
  • candesartan cilexetil + chlorthalidone + amlodipine
  • Exforge HCT® (valsartan 160mg + hydrochlorothiazide 12.5mg + amlodipine 5mg)
  • Rio Branco, AC, Brazil
  • +21 more
Jun 26, 2023

Traumatic Brain Injury Trial in San Francisco (Atorvastatin Calcium, Minocycline Hydrochloride, Candesartan Cilexetil)

Not yet recruiting
  • Traumatic Brain Injury
  • Atorvastatin Calcium
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Apr 12, 2023

COVID-19, SARS-CoV2 Infection Trial in India (Candesartan Cilexetil, Repagermanium, Candesartan Placebo)

Recruiting
  • COVID-19
  • SARS-CoV2 Infection
  • Candesartan Cilexetil
  • +3 more
  • Guntur, India
  • +4 more
Mar 13, 2022

Bioequivalence Trial in Mont-Royal (Candesartan Cilexetil 32mg, Atacand® PROTECT)

Completed
  • Bioequivalence
  • Candesartan Cilexetil 32mg
  • Atacand® PROTECT
  • Mont-Royal, Quebec, Canada
    Altasciences Company Inc.
Nov 15, 2019

Migraine Trial in Estonia, Norway (Candesartan Oral Tablet 8 mg, Candesartan Oral Tablet 16 mg, Placebo oral tablet)

Recruiting
  • Migraine
  • Candesartan Oral Tablet 8 mg
  • +2 more
  • Tartu, Estonia
  • +9 more
Apr 28, 2022

Chronic Heart Failure, High Blood B-type (or Brain) Natriuretic Peptide (BNP) Level Trial in France, Germany, Netherlands

Terminated
  • Chronic Heart Failure
  • High Blood B-type (or Brain) Natriuretic Peptide (BNP) Level
  • olmesartan medoxomil + candesartan cilexetil placebo
  • olmesartan medoxomil placebo + candesartan cilexetil
  • Bron, France
  • +10 more
Dec 20, 2018

Surveillance ?Challenge - Quality Control?

Completed
Has Results
  • Hypertension
  • Candesartan Cilexetil
  • Osaka, Japan
    (unnamed)
Apr 9, 2018

Candesartan Cilexetil / Hydrochlorothiazide Combination Tablets

Completed
Has Results
  • Hypertension
  • Candesartan cilexetil / hydrochlorothiazide
  • Tokyo, Japan
    (unnamed)
Apr 17, 2018

Hypertension Trial in Seoul (Group I, Group II)

Unknown status
  • Hypertension
  • Group I
  • Group II
  • Seoul, Korea, Republic of
    Yonsei University Severance Cardiovascular Hospital
Oct 15, 2018

Candesartan Cilexetil/Amlodipine Besilate Combination Tablets

Completed
Has Results
  • Hypertension
  • Candesartan cilexetil/Amlodipine besilate
  • (no location specified)
Jul 25, 2018

Healthy Volunteers Trial in Amman (Candesartan, Amlodipine, Atorvastatin)

Completed
  • Healthy Volunteers
  • Candesartan, Amlodipine, Atorvastatin
  • Amman, Jordan
    International Pharmaceutical Research Center
Jan 31, 2020

Hypertension Trial in Uppsala (Zestril®, Atacand®, Norvasc®)

Completed
  • Hypertension
  • Uppsala, Sweden
    Uppsala University hospital, Internal medicine research, Oscar I
Aug 31, 2021

Efficacy, Safety Issues Trial in Chula Vista, San Diego (AMIA with SHARESOURCE Connectivity Platform, HomeChoice PRO)

Active, not recruiting
  • Efficacy
  • Safety Issues
  • AMIA with SHARESOURCE Connectivity Platform
  • HomeChoice PRO
  • Chula Vista, California
  • +1 more
Aug 23, 2021

ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

Completed
  • Hypertension
  • COVID
  • Salt Lake City, Utah
    University of Utah
Apr 26, 2021

Hypertension Trial (MK-5478, Comparator: Candesartan cilexetil, Comparator: Pbo)

Completed
Has Results
  • Hypertension
  • (no location specified)
Aug 22, 2018

Hypertension Trial in Hyderabad (Candesartan cilexetil (GW615775, Test formulation), Candesartan cilexetil (Reference

Completed
  • Hypertension
  • Candesartan cilexetil (GW615775, Test formulation)
  • Candesartan cilexetil (Reference treatment)
  • Hyderabad, India
    GSK Investigational Site
Mar 6, 2018

Cardiovascular Disease Trial in Hyderabad (Candesartan Cilexetil in formulation 1, Candesartan Cilexetil in formulation 2,

Completed
  • Cardiovascular Disease
  • Candesartan Cilexetil in formulation 1
  • +2 more
  • Hyderabad, India
    GSK Investigational Site
Mar 8, 2018

Tuberculosis, Pulmonary Trial in Cape Town (Sanfetrinem Cilexetil, Amoxicillin/clavulanic acid, Rifampicin)

Recruiting
  • Tuberculosis, Pulmonary
  • Sanfetrinem Cilexetil
  • +2 more
  • Cape Town, Western Cape, South Africa
    TASK Clinical Research Centre
May 19, 2022

Cardiomyopathy, Dilated Trial (Candesartan)

Recruiting
  • Cardiomyopathy, Dilated
  • Majadahonda, Madrid, Spain
    Hospital Universitario Puerta de Hierro-Majadahonda
Aug 23, 2022

Migraine, Head Pain Trial in Valladolid (Candesartan)

Recruiting
  • Migraine
  • Head Pain
  • Valladolid, Spain
    Hospital Clínico Universitario Valladolid
Feb 9, 2022

Mild Cognitive Impairment Trial in Atlanta (Placebo, Candesartan)

Completed
  • Mild Cognitive Impairment
  • Atlanta, Georgia
  • +1 more
Feb 15, 2022

Type 2 Diabetes and Microalbuminuria Trial in Japan (TAK-272, TAK-272 Placebo, Candesartan cilexetil)

Completed
Has Results
  • Type 2 Diabetes Mellitus and Microalbuminuria
  • Nagoya-shi, Aichi, Japan
  • +67 more
Nov 24, 2017

Bariatric Surgery and Pharmacokinetics of Candesartan

Recruiting
  • Obesity, Morbid
  • Trondheim, Norway
    St. Olavs University Hospital
Mar 21, 2022

Peripheral Neuropathy Trial in Limoges (Candesartan, Usual care)

Terminated
  • Peripheral Neuropathy
  • Limoges, France
    CHU Limoges
Nov 12, 2021

Hypertension Trial in Seoul (Candesartan 16mg, Amlodipine 5mg, Amlodipine 10mg)

Completed
  • Hypertension
  • Candesartan 16mg
  • +2 more
  • Seoul, Korea, Republic of
    Severance Hospital
Aug 23, 2020